-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Transcranial Doppler (ICPtcd) can be used as an alternative noninvasive method to rule out intracranial hypertension (ICP) in the management of patients with acute traumatic brain injury when invasive methods cannot be used
The aim of this study was to determine whether ICPtcd could be considered reliable for the exclusion of intracranial hypertension compared to the reference standard method for invasive ICP monitoring (ICPi).
This is a prospective, international, multicenter, unblinded, diagnostic accuracy study comparing the performance of ICPtcd and ICPi
Diagnostic Stroke Screening
A total of 262 patients were recruited for the final analysis
Thus, ICPtcd has a higher NPV in excluding intracranial hypertension
ICPtcd has a high NPV in excluding intracranial hypertension
Original source:
Frank A.
Transcranial Doppler as a screening test to exclude intracranial hypertension in brain-injured patients: the IMPRESSIT-2 prospective multicenter international study
Leave a comment here